Publicacions en què col·labora amb José Martínez Lanao (28)

2013

  1. Tratado general de biofarmacia y farmacocinética: Volumen I: LADME. Análisis farmacocinético. Biodisponibilidad y bioequivalencia

    Síntesis

2005

  1. Comparative study of the disposition of levofloxacin, netilmicin and cefepime in the isolated rat lung

    Journal of Pharmacy and Pharmacology, Vol. 57, Núm. 7, pp. 861-867

  2. Influence of flow rate on the disposition of levofloxacin and netilmicin in the isolated rat lung

    European Journal of Pharmaceutical Sciences, Vol. 24, Núm. 4, pp. 325-332

2003

  1. Estudio comparativo de la distribución de levofloxacino y netilmicina en pulmón aislado de rata. Influencia del flujo de perfusión

    VI Congreso de la Sociedad Española de Farmacia Industrial y Galénica. 3ª Jornadas de Tecnología Farmecéutica. Granada, 9-11 de febrero de 2003.: Libro de Comunicaciones (Comares), pp. 361-364

2002

  1. In vitro study of experimental factors affecting the microdialysis results

    Analytica Chimica Acta, Vol. 459, Núm. 1, pp. 143-150

  2. Influence of dose on the disposition kinetics of netilmicin in the isolated kidney of the rat

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 27, Núm. 2, pp. 127-133

  3. Influence of the infusion rate on disposition of netilmicin in the isolated rat perfused kidney

    European Journal of Pharmaceutical Sciences, Vol. 16, Núm. 3, pp. 133-141

2000

  1. A review of the isolated kidney as an experimental model for pharmacokinetic studies

    Methods and Findings in Experimental and Clinical Pharmacology, Vol. 22, Núm. 10, pp. 757-763

1999

  1. Distribution of ciprofloxacin in the isolated rat lung in the presence and absence of tissue oedema

    European Journal of Pharmaceutical Sciences, Vol. 8, Núm. 3, pp. 203-209

1998

  1. A comparative study of ofloxacin and ciprofloxacin erythrocyte distribution

    Biopharmaceutics and Drug Disposition, Vol. 19, Núm. 2, pp. 71-77

  2. In vitro characterization of ciprofloxacin distribution in rat lung

    Methods and Findings in Experimental and Clinical Pharmacology, Vol. 20, Núm. 5, pp. 369-375

  3. Pharmacokinetic parameters of netilmicin and protective effect of piperacillin regarding nephrotoxicity caused by netilmicin

    European Journal of Drug Metabolism and Pharmacokinetics

1997

  1. Study on pharmacokinetics and nephrotoxicity of netilmicin in rabbits using a new dosage regimen

    Methods and Findings in Experimental and Clinical Pharmacology, Vol. 19, Núm. 1, pp. 53-59

1993

  1. Tissue Distribution Pharmacokinetics of Ciprofloxacin vs Ofloxacin in Rabbits

    Drugs, Vol. 45, Núm. 3, pp. 248-249

1990

  1. Effect of renal impairment on distribution of ofloxacin

    Antimicrobial Agents and Chemotherapy, Vol. 34, Núm. 3, pp. 455-459

  2. Optimization of dosage regimens of aminoglycoside antibiotics in the presence of beta-lactam agents by simulation techniques

    Acta Pharmaceutica Jugoslavica, Vol. 40, Núm. 2 SUPPL. 1, pp. 301-308

1989

  1. Pharmacokinetic and nephrotoxic study of gentamicin in rabbits using a new dosage regimen

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 14, Núm. 2, pp. 169-175

  2. Ultrastructural effects of gentamicin at therapeutic doses on the renal cortex

    Revista Espanola de Quimioterapia, Vol. 2, Núm. 1, pp. 73-77

1987

  1. Effect of mode of administration on distribution of dibekacin in rabbits

    Journal of Antimicrobial Chemotherapy, Vol. 19, Núm. 6, pp. 799-806

  2. In vitro interaction between HAPA-gentamicin B and penicillins

    International Journal of Pharmaceutics, Vol. 37, Núm. 1-2, pp. 113-117